Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort. - Ali HM; Mazzoni S; Goel U; Khouri J; Anwer F; Williams LS; Basali D; Samaras CJ; Faiman BM; Van Heeckeren W; Hamilton K; Rudoni J; et al. (Blood cancer journal, 2026)